Related Experiment Videos
Attitudes toward clinical trials among patients and the public
Abstract:
Attitudes toward clinical research, the focus of recent and damaging media attention, were assessed through questionnaires completed anonymously by 104 patients with cancer, 84 cardiology patients, and 107 members of the general public. Responses differed neither by subgroup nor by demographic variables. Data are therefore reported on the total population of 295 subjects. Most respondents (71%) believed that patients should serve as research subjects. In support of this belief, the majority cited potential benefit ot others and the opportunity to increase scientific knowledge, but a different bias emerged when they were asked about their own potential participation. This study shows that diverse respondents view clinical trials as important, ethical, and as a means of attaining superior clinical care. Major importance is attributed to making contributions to medical knowledge and to helping future patients. Contrasts are noted in patients' views of their own treatments v treatments of "'hypothetical others."
Insights
Most people believe clinical trials are important and ethical, benefiting others and advancing science. However, individuals show a bias when considering their own participation in research.
Area of Science:
- Medical research ethics
- Public health attitudes
- Clinical trial participation
Background:
- Recent media attention has negatively impacted public perception of clinical research.
- Understanding public attitudes is crucial for the success of clinical trials.
Purpose of the Study:
- To assess public and patient attitudes toward clinical research.
- To identify factors influencing willingness to participate in clinical trials.
Main Methods:
- Anonymous questionnaires administered to 295 participants (cancer patients, cardiology patients, general public).
- Data analyzed across demographic variables and subgroups.
Main Results:
- 71% of respondents believed patients should participate in research.
- Motivations included potential benefit to others and advancing scientific knowledge.
- A bias was observed regarding personal participation versus hypothetical others.
Conclusions:
- Diverse populations view clinical trials as important, ethical, and a pathway to superior care.
- Contributions to medical knowledge and helping future patients are key motivators.
- A discrepancy exists between views on personal and hypothetical patient treatment in clinical trials.